Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › 5-[[4-[2-[5-(1-hydroxyethyl)pyridin-2-yl]ethoxy]phenyl]methyl]-1,3-thiazolidine-2,4-dione and its salts for use in the treatment of mitochondrial diseases

5-[[4-[2-[5-(1-hydroxyethyl)pyridin-2-yl]ethoxy]phenyl]methyl]-1,3-thiazolidine-2,4-dione and its salts for use in the treatment of mitochondrial diseases

US Patent 11957670 · Granted Apr 16, 2024

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

5-[[4-[2-[5-(1-hydroxyethyl)pyridin-2-yl]ethoxy]phenyl]methyl]-1,3- thiazolidine2024
5-[[4-[2-[5-(1-hydroxyethyl)pyridin-2-yl]ethoxy]phenyl]methyl]-1,3- thiazolidine2024
Isoquinoline compounds, methods for their preparation, and therapeutic uses ther2022
Isoquinoline compounds, methods for their preparation, and therapeutic uses ther2022
(Hetero)aryl cyclopropylamine compounds as LSD1 inhibitors2019
Arylcyclopropylamine based demethylase inhibitors of LSD1 and their medical use2019
(Hetero)aryl cyclopropylamine compounds as LSD1 inhibitors2019
2,4-thiazolidinedione derivatives in the treatment of central nervous system dis2019
2,4-thiazolidinedione derivatives in the treatment of central nervous system dis2019
(Hetero)aryl cyclopropylamine compounds as LSD1 inhibitors2018
Lysine demethylase inhibitors for myeloproliferative disorders2018
2,4-thiazolidinedione derivatives in the treatment of central nervous system dis2017